User's Manual

ManualsBrandsSORIN CRM ManualsElectronicsImplantable cardioverter defibrillator with RF wireless communication availability

Table Of Contents

1. General description
2. Indications
3. Contraindications
4. Warnings and precautions
- 4.1. Risks related to medical environment
- 4.2. Sterilization, storage and handling
- 4.3. Implantation and device programming
- 4.4. Lead evaluation and lead connection
- 4.5. Generator explant and disposal
5. Adverse events
- 5.1. Defender study
  - Table 1: Summary of European Clinical Complications
  - Table 2: Summary of European Clinical Complications
6. Clinical studies
- 6.1. Defender study
7. Patient selection and treatment
- 7.1. Individualization of treatment
- 7.2. Specific patient populations
8. Patient counselling information
9. Declaration of conformity
10. Physician guidelines
- 10.1. Physician training
- 10.2. Directions for use
- 10.3. Maintaining device quality
11. Patient information
12. How supplied
- 12.1. Sterility
- 12.2. Warranty and replacement policy
13. Device description
14. Implant procedure
- 14.1. Necessary equipment
- 14.2. Packaging
  - 14.2.1. Contents
- 14.3. Optional equipment
- 14.4. Before opening the package
- 14.5. Prior to implantation
- 14.6. Device placement
- 14.7. Choosing the type of lead
- 14.8. Shock configuration (+ -> -)
- 14.9. Measurement of thresholds at implant
- 14.10. Lead connection
- 14.11. Device implantation
- 14.12. Tests and programming
15. Special modes
- 15.1. Safety mode (nominal values)
- 15.2. Magnet mode
- 15.3. Response in the presence of disturbance
- 15.4. Detection characteristics in the presence of electromagnetic fields
- 15.5. Protection against short-circuits
16. Main functions
- 16.1. Automatic lead measurements
- 16.2. Ventricular tachyarrhythmia management
- 16.3. Pacing
- 16.4. Sensing
- 16.5. Follow-up function
- 16.6. Remote Monitoring function
17. Patient follow-up
- 17.1. Follow-up recommendations
- 17.2. Holter Function
  - Stored Tachyarrythmia Episodes:
  - Therapy history
- 17.3. Recommended Replacement Time (RRT)
- 17.4. Explantation
- 17.5. Defibrillator identification
18. Physical characteristics
- 18.1. Materials used
19. Electrical characteristics
- 19.1. Table of delivered shock energy and voltage
- 19.2. Battery
- 19.3. Longevity
20. Programmable parameters
- 20.1. Antibradycardia pacing
- 20.2. Ventricular tachyarrhythmia detection
- 20.3. Ventricular tachyarrhythmia therapies
- 20.4. Remote alerts and warnings
21. Non programmable parameters
22. Limited warranty
23. Patents
24. Explanation of symbols

20. PROGRAMMABLE PARAMETERS

20.2. VENTRICULAR TACHYARRHYTHMIA DETECTION

Therapy zones Values

Slow VT detection zone Slow VT ON-Slow VT OFF

VT detection zone VT ON-VT OFF

Fast VT / VF detection zone Fast VT+VF ON-VF ON

Slow VT rate (lower limit) (ppm) From 100 to 200 by steps of 5 ; 190

VT rate (lower limit) (ppm) 130-135-140-145-150-155-160-165-170-175-180-185-190-

195-200-210-220-230

VF rate (lower limit) (ppm) 150-155-160-165-170-175-180-185-190-195-200-210-220-

230-240

Fast VT rate (upper limit) (ppm) 155-160-165-170-175-180-185-190-195-200-210-220-230-

240-255

Slow VT persistence (cycles) 4-6-8-12-16-20-30-50-100-200

VT persistence (cycles) 4-6-8-12-16-20-30-50-100-200

VF persistence (cycles) From 4 to 20 by steps of 1 ; 6

Detection criteria Values

Slow VT and VT detection criteria Rate Only-Stability-Stability+-Stability/Acc-Stability+/Acc

Fast VT detection criteria Rate+Stability-Rate Only

Majority: (X/Y), Y (cycles) 8-12-16

Majority: (X/Y), X (%) 65-70-75-80-90-95-100

Window of RR stability for Slow VT

and VT (ms)

30-45-65-80-95-110-125

Window of RR stability for fast VT

(ms)

30-45-65

Acceleration (%) 6-13-19-25-31-38-44-50

Long cycle persistence extension

(cycles)

From 0 to 16 by steps of 1 ; 10

Long cycle gap (ms) 15-30-45-65-80-95-110-125-140-155-170-190-205

SORIN – PLATINIUM VR – U461A